Mergers & Acquisitions ruling the Indian Pharma market too?

-
Lupin Ltd., India's second-largest drugmaker by market value, and Cipla Ltd. are among companies that bid for UCB SA's U.S. generic-drug business. The Indian companies submitted first-round offers for UCB's Kremers Urban Pharmaceuticals Inc. unit in late April. The business could be valued at about $1 billion. The Brussels-based drugmaker is selling Kremers Urban as it focuses on drugs for central nervous system illnesses and immunology.

Indian drugmakers have been considering acquisitions to better compete with market leader Sun Pharmaceutical Industries Ltd after it acquired domestic rival Ranbaxy Laboratories Ltd. Dr. Reddy's Laboratories Ltd., based in Hyderabad, has already agreed to buy UCB's brands in India for 118 million euros ($129 million).

Source: http://timesofindia.indiatimes.com/business/international-business/Lupin-Cipla-Said-to-Bid-for-UCBs-1-billion-US-generics-unit/articleshow/47507952.cms

Comments

Post a Comment

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

-
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues.  Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour.  Among other dignitaries, Dr. Anil Kumar Rai, Consulate Ge...
Read more

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

-
Image
“IDEA TO MARKET” is an idea hunt to commercialize the herbal inventions. It is a platform for researchers to use their innovative ideas in the area of herbal research and get the products commercialized in collaboration with corporate partners.  Hurry up and register for the webinar to know more about this program. The webinar is organized by Bombay College of Pharmacy and Pharma Literati.  Registration Link for webinar on OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH: https://docs.google.com/forms/d/e/1FAIpQLSfUhe1LtCOjG50SilFw_iECnzBXu4CW0nK2wIvd8QVVvpDOzQ/viewform
Read more

WhatsApp Group for Pharma Literati

-
We recently announced about the launch of students' career guidance facility. Please see: http://pharmaliterati.blogspot.in/2015/08/pharmacy-students-guidance-facility.html We are please to announce the creation of WhatsApp group for Pharma Literati with following features: 1. The blog posts would be instantly shared with the group. 2. Group specific activities like job opportunities and exclusive events. 3. One of its kind of activities to get in touch with the industry, academia, students and discuss the pharmacy related topics. Request our readers to send an email to pharmaliterati@gmail.com or send an SMS/ WhatsApp message to 09769059971 to get added in this group. Team Pharma Literati 
Read more